Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma (HCC): Asia-Pacific (AP) trial subgroup analyses by baseline transaminase (ALT/AST)/α-fetoprotein (AFP) levels

Shenghui Qin, Ann‐Lii Cheng, Won Young Tak et al.|Journal of Clinical Oncology|2009

Cited by 1